Lau, L <br/><br/>
Cyclooxygenase inhibitors modulate the p53/HDM2 pathway and enhance chemotherapy-induced apoptosis in neuroblastoma.  [electronic resource] 

 -  Oncogene  Mar 2007 
 - 1920-31 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0950-9232 
<br/><br/><label>Standard No.: </label>10.1038/sj.onc.1209981  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Base Sequence<br/>Cell Line, Tumor<br/>Cell Nucleus--metabolism<br/>Cyclooxygenase Inhibitors--pharmacology<br/>Flow Cytometry<br/>Fluorescent Antibody Technique<br/>Humans<br/>Neuroblastoma--metabolism<br/>Phosphorylation<br/>Proto-Oncogene Proteins c-mdm2--metabolism<br/>RNA, Small Interfering<br/>Tumor Suppressor Protein p53--metabolism